Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

  1. del Rio, M.-L.
  2. Bravo Moral, A.M.
  3. Fernandez-Renedo, C.
  4. Buhler, L.
  5. Perez-Simon, J.-A.
  6. Chaloin, O.
  7. Alvarez Nogal, R.
  8. Fernandez-Caso, M.
  9. Rodriguez-Barbosa, J.-I.
Journal:
Translational Research

ISSN: 1878-1810 1931-5244

Year of publication: 2017

Volume: 181

Pages: 83-95.e3

Type: Article

DOI: 10.1016/J.TRSL.2016.09.004 GOOGLE SCHOLAR

Sustainable development goals